Compare TSCO & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSCO | RMD |
|---|---|---|
| Founded | 1938 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.6B | 36.4B |
| IPO Year | 1994 | 1995 |
| Metric | TSCO | RMD |
|---|---|---|
| Price | $52.33 | $243.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 13 |
| Target Price | $63.10 | ★ $290.00 |
| AVG Volume (30 Days) | ★ 5.5M | 896.9K |
| Earning Date | 01-29-2026 | 01-29-2026 |
| Dividend Yield | ★ 1.72% | 0.98% |
| EPS Growth | 0.57 | ★ 29.59 |
| EPS | 2.07 | ★ 9.77 |
| Revenue | ★ $15,399,257,000.00 | $5,257,400,000.00 |
| Revenue This Year | $7.32 | $9.85 |
| Revenue Next Year | $6.54 | $7.32 |
| P/E Ratio | $25.85 | ★ $25.17 |
| Revenue Growth | 4.26 | ★ 9.36 |
| 52 Week Low | $46.85 | $199.92 |
| 52 Week High | $63.99 | $293.81 |
| Indicator | TSCO | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 38.98 |
| Support Level | $51.55 | $243.62 |
| Resistance Level | $53.73 | $255.83 |
| Average True Range (ATR) | 1.13 | 5.84 |
| MACD | -0.01 | -0.35 |
| Stochastic Oscillator | 23.04 | 25.55 |
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,335 of its namesake banners in 49 states, along with 207 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2024, revenue consisted primarily of livestock, equine & agriculture (26%), companion animal (25%), and seasonal & recreation (23%).
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.